These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 20662247)

  • 21. CpG motifs for optimization of DNA vaccines.
    Davis HL
    Dev Biol (Basel); 2000; 104():165-9. PubMed ID: 11713816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA.
    Jakob T; Walker PS; Krieg AM; Udey MC; Vogel JC
    J Immunol; 1998 Sep; 161(6):3042-9. PubMed ID: 9743369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural requirements for uptake and recognition of CpG oligonucleotides.
    Heeg K; Dalpke A; Peter M; Zimmermann S
    Int J Med Microbiol; 2008 Jan; 298(1-2):33-8. PubMed ID: 17706458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge.
    Krieg AM; Love-Homan L; Yi AK; Harty JT
    J Immunol; 1998 Sep; 161(5):2428-34. PubMed ID: 9725240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Plasmid encoding human IL-12 improve protective efficacy of Mtb8.4 gene vaccine with signal sequence against infection of Mycobacterium Tuberculosis].
    Li H; Li R; Zhong S; Ren H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):291-4. PubMed ID: 17428378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides.
    Yi AK; Chace JH; Cowdery JS; Krieg AM
    J Immunol; 1996 Jan; 156(2):558-64. PubMed ID: 8543806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
    Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
    APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge.
    Vipond J; Vipond R; Allen-Vercoe E; Clark SO; Hatch GJ; Gooch KE; Bacon J; Hampshire T; Shuttleworth H; Minton NP; Blake K; Williams A; Marsh PD
    Vaccine; 2006 Sep; 24(37-39):6340-50. PubMed ID: 16781800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis.
    Castañon-Arreola M; López-Vidal Y; Espitia-Pinzón C; Hernández-Pando R
    Tuberculosis (Edinb); 2005; 85(1-2):115-26. PubMed ID: 15687035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigen.
    Baral RN; Saha A; Chatterjee S; Foon KA; Krieg A; Weiner GJ; Bhattacharya-Chatterjee M
    Cancer Immunol Immunother; 2003 May; 52(5):317-27. PubMed ID: 12700947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J; Adamsson J; Harandi AM
    Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN.
    de Jong S; Chikh G; Sekirov L; Raney S; Semple S; Klimuk S; Yuan N; Hope M; Cullis P; Tam Y
    Cancer Immunol Immunother; 2007 Aug; 56(8):1251-64. PubMed ID: 17242927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of CpG oligodeoxynucleotides as immune adjuvants.
    Klinman DM; Currie D; Gursel I; Verthelyi D
    Immunol Rev; 2004 Jun; 199():201-16. PubMed ID: 15233736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re-formulation of selected DNA vaccine candidates and their evaluation as protein vaccines using a guinea pig aerosol infection model of tuberculosis.
    Vipond J; Clark SO; Hatch GJ; Vipond R; Marie Agger E; Tree JA; Williams A; Marsh PD
    Tuberculosis (Edinb); 2006; 86(3-4):218-24. PubMed ID: 16520093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
    Andersen JM; Al-Khairy D; Ingalls RR
    Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic peptide vaccination in cattle: induction of strong cellular immune responses against peptides derived from the Mycobacterium bovis antigen Rv3019c.
    Vordermeier HM; Pontarollo R; Karvonen B; Cockle P; Hecker R; Singh M; Babiuk LA; Hewinson RG; van Drunen Littel-van Den Hurk S
    Vaccine; 2005 Aug; 23(35):4375-84. PubMed ID: 15908057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice.
    Obermeier F; Dunger N; Deml L; Herfarth H; Schölmerich J; Falk W
    Eur J Immunol; 2002 Jul; 32(7):2084-92. PubMed ID: 12115630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oligodeoxynucleotides containing CpG motifs can induce T cell-dependent arthritis in rats.
    Svelander L; Erlandsson Harris H; Lorentzen JC; Trollmo C; Klareskog L; Bucht A
    Arthritis Rheum; 2004 Jan; 50(1):297-304. PubMed ID: 14730628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
    Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.